Patent · US Active

Compounds modifying apoptosis

US8318717B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 23, 2006
Grant dateNov 27, 2012
Priority date
Expiry dateNov 26, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/11
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds capable of inhibiting binding of the Smac protein to Inhibitors of apoptosis (IAPs). Such compounds are preferably capable of inhibiting IAP and thus may promote apoptosis or sensitize cells for apoptosis. The compounds may be used in the treatment of proliferative diseases, such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.